Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.

Dobson R, Topping J, Giovannoni G.

J Med Virol. 2013 Jan;85(1):128-31. doi: 10.1002/jmv.23446.

PMID:
23154877
2.

Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.

de Ory F, Guisasola ME, Sanz JC, García-Bermejo I.

Clin Vaccine Immunol. 2011 Mar;18(3):444-8. doi: 10.1128/CVI.00486-10. Epub 2010 Dec 29.

3.

Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.

Nebel-Schickel H, Hinderer W, Saavedra C, Schmutzler R, Horn J, Vornhagen R, Sonneborn HH.

Beitr Infusionsther Transfusionsmed. 1994;32:134-7.

PMID:
9422107
4.

Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma.

Gu AD, Mo HY, Xie YB, Peng RJ, Bei JX, Peng J, Li MY, Chen LZ, Feng QS, Jia WH, Zeng YX.

Clin Vaccine Immunol. 2008 Nov;15(11):1684-8. doi: 10.1128/CVI.00135-08. Epub 2008 Sep 3.

5.

[Detection of serum Epstein-Barr virus antibody level by ELISA in normal populations and nasopharyngeal carcinoma patients in Zhongshan City of China].

Cheng MT, Cheng WM, Ji MF, Liang JS.

Di Yi Jun Yi Da Xue Xue Bao. 2002 Sep;22(9):817-8, 822. Chinese.

PMID:
12297441
6.

Evaluation of a new ELISA for the detection of specific IgG to the Epstein-Barr nuclear antigen 1 (EBNA-1).

Schenk BI, Michel PO, Enders G, Thilo N, Radtke M, Oker-Blom C, Franke D.

Clin Lab. 2007;53(3-4):151-5.

PMID:
17447651
7.

IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.

Ayadi W, Karray-Hakim H, Feki L, Khabir A, Boudawara T, Ghorbel A, Daoud J, Frikha M, Hammami A.

J Med Virol. 2009 Aug;81(8):1412-21. doi: 10.1002/jmv.21532.

PMID:
19551836
8.

A systematic study of Epstein-Barr virus serologic assays following acute infection.

Rea TD, Ashley RL, Russo JE, Buchwald DS.

Am J Clin Pathol. 2002 Jan;117(1):156-61.

PMID:
11789721
9.

Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.

Färber I, Hinderer W, Rothe M, Lang D, Sonneborn HH, Wutzler P.

J Med Virol. 2001 Apr;63(4):271-6.

PMID:
11241457
10.

[Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].

Martínez Zapico R, Sobejano L, Llamazares I, Ladrón de Guevara C.

Enferm Infecc Microbiol Clin. 1992 May;10(5):281-3. Spanish.

PMID:
1327168
11.

Study on sero-diagnosis of nasopharyngeal carcinoma using a dual antibody test against recombinant Epstein-Barr virus antigens.

Gu YL, Zhang CQ, Ng SP, Zong YS, Liang YJ, Chen YL.

Ai Zheng. 2003 Sep;22(9):903-6.

PMID:
12969518
12.

Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile.

García T, Tormo N, Gimeno C, Navarro D.

J Infect. 2008 Oct;57(4):351-3. doi: 10.1016/j.jinf.2008.07.017. Epub 2008 Sep 11. No abstract available.

PMID:
18789535
13.
15.
16.

Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1.

Inoue N, Kuranari J, Harada S, Nakajima H, Ohbayashi M, Nakamura Y, Miyasaka N, Ezawa K, Ban F, Yanagi K.

J Clin Microbiol. 1992 Jun;30(6):1442-8.

17.

Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.

Chen JJ, Liu TC, Liang QN, Dong ZN, Wu YS, Li M.

J Med Virol. 2015 Nov;87(11):1940-5. doi: 10.1002/jmv.24247. Epub 2015 Jun 30.

PMID:
26129643
18.

Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.

Ingram G, Bugert JJ, Loveless S, Robertson NP.

Eur J Neurol. 2010 Nov;17(11):1386-9. doi: 10.1111/j.1468-1331.2010.03083.x.

PMID:
20482607
19.
20.

Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.

Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.

J Med Virol. 2003 Aug;70(4):617-23.

PMID:
12794726

Supplemental Content

Support Center